Ramsay Générale de Santé S.A. | Large-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2014

Income Metrics

Revenue 312.5M
Gross Profit 224.6M 71.87%
Operating Income 17.8M 5.70%
Net Income -7.7M -2.46%

Balance Sheet Metrics

Total Assets 6.8B
Total Liabilities 5.7B
Shareholders Equity 1.2B
Debt to Equity 4.79

Cash Flow Metrics

Operating Cash Flow 28.5M
Free Cash Flow 48.7M

Revenue & Profitability Trend

Ramsay Générale de Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i5.2B5.0B4.7B4.3B4.0B
Cost of Goods Sold i1.2B1.1B978.8M890.7M818.6M
Gross Profit i4.1B3.9B3.7B3.4B3.2B
Gross Margin % i77.9%78.7%79.2%79.3%79.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i719.2M678.9M516.3M749.1M704.3M
Total Operating Expenses i719.2M678.9M516.3M749.1M704.3M
Operating Income i187.4M184.2M218.2M293.7M265.9M
Operating Margin % i3.6%3.7%4.6%6.8%6.6%
Non-Operating Items
Interest Income i4.7M2.9M9.3M600.0K800.0K
Interest Expense i199.1M177.0M156.4M114.6M121.3M
Other Non-Operating Income-----
Pre-tax Income i-33.4M-40.8M87.7M185.2M103.3M
Income Tax i1.6M-4.1M23.8M57.3M29.5M
Effective Tax Rate % i0.0%0.0%27.1%30.9%28.6%
Net Income i-38.1M-36.7M63.9M127.8M73.8M
Net Margin % i-0.7%-0.7%1.4%3.0%1.8%
Key Metrics
EBITDA i599.7M562.9M647.3M666.5M634.9M
EPS (Basic) i-€-0.49€0.45€1.07€0.59
EPS (Diluted) i-€-0.49€0.45€1.07€0.59
Basic Shares Outstanding i-110000000109777778110369389110364389
Diluted Shares Outstanding i-110000000109777778110369389110364389

Income Statement Trend

Ramsay Générale de Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i366.5M359.0M352.2M132.5M608.4M
Short-term Investments i17.5M22.3M10.7M11.0M11.6M
Accounts Receivable i527.5M687.2M538.6M422.0M323.4M
Inventory i125.1M125.0M118.2M111.2M111.4M
Other Current Assets260.7M269.3M329.0M574.0M406.4M
Total Current Assets i1.3B1.5B1.4B1.3B1.5B
Non-Current Assets
Property, Plant & Equipment i3.0B1.8B1.7B1.6B1.5B
Goodwill i4.4B4.4B4.3B4.4B3.8B
Intangible Assets i205.5M209.0M213.7M244.8M241.1M
Long-term Investments-7.8M31.9M00
Other Non-Current Assets-100.0K400.0K-100.0K-
Total Non-Current Assets i5.5B5.4B5.6B5.5B5.2B
Total Assets i6.8B6.9B7.0B6.8B6.7B
Liabilities
Current Liabilities
Accounts Payable i432.3M457.8M471.9M410.8M343.8M
Short-term Debt i335.0M355.8M279.6M231.4M237.0M
Current Portion of Long-term Debt-----
Other Current Liabilities811.1M830.9M699.6M775.6M901.8M
Total Current Liabilities i1.6B1.7B1.5B1.5B1.6B
Non-Current Liabilities
Long-term Debt i3.7B3.7B3.9B3.7B3.6B
Deferred Tax Liabilities i29.4M17.2M52.8M39.7M51.2M
Other Non-Current Liabilities16.2M3.7M3.7M8.9M10.2M
Total Non-Current Liabilities i4.0B4.0B4.2B4.1B4.0B
Total Liabilities i5.7B5.7B5.7B5.5B5.6B
Equity
Common Stock i82.7M82.7M82.7M82.7M82.7M
Retained Earnings i-54.1M-53.9M49.4M118.4M65.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.2B1.2B1.3B1.2B1.1B
Key Metrics
Total Debt i4.1B4.1B4.1B4.0B3.9B
Working Capital i-314.2M-219.4M-126.4M-230.0M-82.1M

Balance Sheet Composition

Ramsay Générale de Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-38.1M-36.7M63.9M127.8M73.8M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i112.7M4.6M25.8M-347.0M-14.0M
Operating Cash Flow i298.5M192.9M220.2M-123.3M228.5M
Investing Activities
Capital Expenditures i-135.8M-166.6M-165.1M-175.4M-173.9M
Acquisitions i-3.8M-14.3M-11.4M-296.4M-8.1M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-140.0M-180.9M-176.5M-471.8M-182.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i63.1M70.4M200.8M200.0M1.6B
Debt Repayment i-148.2M-56.0M-14.8M-112.4M-1.6B
Financing Cash Flow i-81.4M17.7M189.5M87.6M-61.4M
Free Cash Flow i550.9M418.3M426.7M68.9M475.9M
Net Change in Cash i77.1M29.7M233.2M-507.5M-14.9M

Cash Flow Trend

Ramsay Générale de Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.13
Price to Book 0.94
Price to Sales 0.21

Profitability Ratios

Profit Margin -1.03%
Operating Margin 3.58%
Return on Equity -2.90%
Return on Assets 1.71%

Financial Health

Current Ratio 0.81
Debt to Equity 343.66
Beta 0.19

Per Share Data

EPS (TTM) €-0.46
Book Value per Share €10.37
Revenue per Share €47.48

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
gds1.1B34.130.94-2.90%-1.03%343.66
Emeis S.A 2.0B0.021.14-23.02%-7.31%514.45
Orpea 1.9B0.10-71.75%79.36%4.85
Clariene SE 1.5B9.760.42-1.54%-1.16%209.58
Lna Santé S.A 270.0M13.420.867.25%2.71%270.87
EssilorLuxottica 126.5B53.383.356.44%8.74%36.58

Financial data is updated regularly. All figures are in the company's reporting currency.